Skip to content
Dr. Tashko’s badge from the Better Business Bureau displays an “Accredited Business” seal with an A+ rating as of July 9, 2025 for GT Health practice. The design features the BBB torch logo on the left and a clickable prompt for profile access on the right, reinforcing professional credibility, transparency, and excellence in patient care and business ethics.
🗨️ Text Us Securely

Fees | Join Our Practice

  • Home
  • Dr. Tashko
    • Profile
    • My Philosophy
    • Featured in Montgomery Magazine
    • Featured in Washingtonian
    • Publications
  • Reviews
  • Benefits
    • Personalized & Integrative Care
    • Our Unique Approach
    • FAQs
  • Services
    • Endocrinology
    • Diabetes
    • Lipidology
    • Hypertension
    • Weight Loss
    • Heart
    • Women’s Health
    • Testosterone, TRT
    • Thyroid
    • Parathyroid
    • Adrenal
    • Pituitary
    • Gynecomastia
    • PCOS
    • Osteoporosis
    • Calcium
    • Longevity
    • Clinical Trials
    • Energy Metabolism
    • Fitness
    • More…
  • Become a Patient
    • Join Our Practice
    • Fees
    • A Letter to My Patients
  • Resources
    • Articles and Posts
    • Key Clinical Trials
    • Clinical Guidelines
    • Personal Interests
    • Search 🔎
  • Contact Us

Maternal Health Information

  • Intrahepatic Cholestasis of Pregnancy (ICP)

    Intrahepatic Cholestasis of Pregnancy (ICP)

    Intrahepatic Cholestasis of Pregnancy (ICP) is a liver condition unique to pregnancy. It disrupts normal bile flow from the liver, causing bile acids to spill into the bloodstream. While uncommon, this condition can pose significant risks to the unborn baby.

    Published

    May 3, 2025
    Categorized as Insights from Dr. Tashko, Liver Health, Maternal Health Information, Women’s Health
  • Thyroid hormones supplementation in pregnant women with Hashimoto’s thyroiditis

    Thyroid hormones supplementation in pregnant women with Hashimoto’s thyroiditis

    Thyroid hormones supplementation 50 mcg daily did not improve pregnancy outcomes in women with Hashimoto’s thyroiditis in the presence of normal thyroid function.  Hashimoto’s thyroiditis was confirmed by elevated TPO antibodies at study entry. About 1,000 pregnant women were followed through full term. This is an important study as it defies the current medical opinion of poorer pregnancy outcomes in euthyroid Hashimoto’s thyroiditis. GT

    Published

    May 24, 2019
    Categorized as Blog, Insights from Dr. Tashko, Maternal Health Information, Thyroid Health
  • Metformin found to be safe during pregnancy

    Metformin found to be safe during pregnancy

    The study found no major adverse events of metformin during pregnancy. This is good news as metformin is an important intervention for hyperglycemia of pregnancy. The following birth outcomes were assessed: cesarean section, neonatal weight, and serious neonatal adverse events. GT

    Published

    May 17, 2019
    Categorized as Blog, Diabetes Care, Insights from Dr. Tashko, Maternal Health Information
  • Congenital malformations in Grave’s disease

    Congenital malformations in Grave’s disease

    Traditional approach is to use propylthiouracil (PTU) for Grave’s disease during the first trimester. This article points otherwise, that both methimazole and PTU can increase the risk of congenital malformations when used in the first three months of pregnancy. I suspect more research would be needed before changing guidelines or standard of care. GT

    Published

    January 19, 2018
    Categorized as Blog, Insights from Dr. Tashko, Maternal Health Information, Thyroid Health
  • Low dose aspirin can help with pregnancy

    Low dose aspirin can help with pregnancy

    An important study showing that low-dose aspirin (LDA) 81 mg/day can increase fertility and successful pregnancy in women with mild chronic inflammation and prior miscarriage. Chronic inflammation is documented by elevated hsCRP. A clinical implication could be checking hsCRP in women with history of pregnancy loss, and if elevated to prescribe low-dose aspirin. LDA has been found safe during pregnancy, while full-dose aspirin should be avoided during the third trimester. GT

    Published

    June 3, 2017
    Categorized as Blog, Insights from Dr. Tashko, Maternal Health Information
  • Glyburide vs. Metformin during pregnancy

    Glyburide vs. Metformin during pregnancy

    This randomized controlled study shows that glyburide and metformin are comparable in management of gestational diabetes. There is tendency for metformin to be somewhat superior however, given less insulin use as second line therapy. GT

    Published

    April 1, 2017
    Categorized as Blog, Diabetes Care, Insights from Dr. Tashko, Maternal Health Information
  • Subclinical Hypothyroidism and Hypothyroxinemia during pregnancy

    Subclinical Hypothyroidism and Hypothyroxinemia during pregnancy

    Pregnant women with subclinical hypothyroidism or hypothyroxinemia received thyroid hormone supplementation or placebo. Compared to placebo, thyroid hormone did not improve children’s cognition at age five. Although results are negative, the study is incomplete for two reasons: Levothyroxine was not initiated until week 17 of gestation. For more meaningful results, thyroid hormone should be started before pregnancy or very early in the first trimester.Longer follow up of 10-15 years would be more appropriate in evaluating…

    Published

    March 22, 2017
    Categorized as Blog, Insights from Dr. Tashko, Maternal Health Information, Thyroid Health
  • 2017 ATA Guidelines: Thyroid & Pregnancy (Part 2)

    2017 ATA Guidelines: Thyroid & Pregnancy (Part 2)

    ATA has “developed evidence-based recommendations to inform clinical decision making in the management of thyroid disease in pregnant and postpartum women. While all care must be individualized, such recommendations provide, in our opinion, optimal care paradigms for patients with these disorders” Part 2 of recommendations are listed with slightly modified wording for easier and succinct reading: GT

    Published

    February 19, 2017
    Categorized as Blog, Clinical Guidelines, Insights from Dr. Tashko, Maternal Health Information, Thyroid Health
  • 2017 ATA Guidelines: Thyroid & Pregnancy (part 1)

    2017 ATA Guidelines: Thyroid & Pregnancy (part 1)

    ATA has “developed evidence-based recommendations to inform clinical decision making in the management of thyroid disease in pregnant and postpartum women. While all care must be individualized, such recommendations provide, in our opinion, optimal care paradigms for patients with these disorders” Part 1 of recommendations are listed with slightly modified wording for easier and succinct reading: GT

    Published

    January 28, 2017
    Categorized as Blog, Clinical Guidelines, Insights from Dr. Tashko, Maternal Health Information, Thyroid Health

The only US physician board-certified in:

❥ Endocrinology, Diabetes and Metabolism

❥ Obesity Medicine

❥ Hypertension

❥ Lipidology

Dr. Tashko’s badge from the Better Business Bureau displays an “Accredited Business” seal with an A+ rating as of July 9, 2025 for GT Health practice. The design features the BBB torch logo on the left and a clickable prompt for profile access on the right, reinforcing professional credibility, transparency, and excellence in patient care and business ethics.
🗨️ Text Our Office Securely

T

301.658.3586

F

240.427.4704

E

admin@GThealth.net

15204 Omega Drive
Suite 240
Rockville, MD 20850

Dr. Tashko is quadruple board-certified in endocrinology, lipidology, hypertension, and obesity medicine. He specializes in diabetes, metabolism, and longevity care, offering integrative, evidence-based solutions for insulin resistance, metabolic syndrome, prediabetes, obesity, and weight management.

He provides advanced cardiovascular prevention and lipid management, focusing on precise control of blood pressure, cholesterol, and triglycerides.

His endocrine expertise covers thyroid and parathyroid disorders, pituitary and adrenal conditions, growth hormone deficiency, Cushing’s syndrome, hyperprolactinemia, and bone health issues such as osteopenia and osteoporosis.

Dr. Tashko also treats low testosterone (TRT), gynecomastia, and polycystic ovary syndrome (PCOS). Each patient receives comprehensive, personalized care centered on metabolic and hormonal balance.

GT Health is based in Rockville, Montgomery County, MD, and serves patients throughout Bethesda, Chevy Chase, Potomac, Gaithersburg, Germantown, Frederick, Silver Spring, Howard County, Anne Arundel, Northern Virginia, and the Eastern Shore. GT Health provides concierge endocrine and metabolic care in Rockville and across Maryland through secure virtual visits.

Medical Conditions
  • Facebook
  • Google
  • LinkedIn
  • Twitter

Copyright

© 2017–2026

Gerti Tashko, M.D.

All Rights Reserved.

“In him all things hold together.”
— Col 1:17